This toolkit was developed to help National TB Program managers and others involved in the management of TB programs develop new National Strategic Plans or improve existing ones.
This multi-lingual, animated video on TB and latent TB infection provides general information using simple messages on how TB is transmitted, the difference between latent TB infection and TB disease as well as what people can do.
This multi-lingual, animated video on TB and latent TB infection provides general information using simple messages on how TB is transmitted, the difference between latent TB infection and TB disease as well as what people can do.
This multi-lingual, animated video on TB and latent TB infection provides general information using simple messages on how TB is transmitted, the difference between latent TB infection and TB disease as well as what people can do.
This multi-lingual, animated video on TB and latent TB infection provides general information using simple messages on how TB is transmitted, the difference between latent TB infection and TB disease as well as what people can do.
This infographic uses an iceberg to demonstrate how many people have latent TB infection and TB disease.
This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
This document provides general guidance and examples on implementing contact investigations in low- and middle-income settings. The World Health Organization (WHO) policy document "Recommendations for Investigating Contacts of Persons with Infectious Tuberculosis in Low- and Middle-Income Countries", published in late 2012, presents definitions and recommendations for what should be done for contact investigation; this document presents suggestions and examples of how the recommendations can be put into operation.
This infographic depicts the global epidemiology of TB.
This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
